SSB
EVLO

Sandy Spring Bank’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Sandy Spring Bank’s Portfolio EVLO Stock Details EVLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-28
Closed -$4K – 1268
2021
Q3 		$4K Hold
28
– – ﹤0.01% 1010
2021
Q2 		$8K Buy
28
+5
+22% +$1.26K ﹤0.01% 934
2021
Q1 		$5K Sell
23
-55
-71% -$15.2K ﹤0.01% 888
2020
Q4 		$19K Buy
78
+58
+290% +$7.17K ﹤0.01% 652
2020
Q3 		$2K Buy
+20
New +$1.82K ﹤0.01% 815

Other funds holding EVLO

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $170M AUM 34.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sandy Spring Bank's EVLO Position: Q4 2021 in Review

Sandy Spring Bank sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q4 2021, closing a stake of 28 shares — an estimated $4K sold.

Sandy Spring Bank first reported a position in EVLO in Q3 2020 and held it in 5 quarters. The position peaked at $19K in Q4 2020. 66 funds tracked by Wall St. Rank hold EVLO as of Q4 2021.

  • Sandy Spring Bank reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Sandy Spring Bank sold 28 Evelo Biosciences, Inc. Common Stock shares in Q4 2021, an estimated $4K.
  • Sandy Spring Bank first reported a position in Evelo Biosciences, Inc. Common Stock in Q3 2020 and held it in 5 quarters.
  • Sandy Spring Bank's Evelo Biosciences, Inc. Common Stock position peaked at $19K in Q4 2020.
  • 66 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q4 2021.

Based on Sandy Spring Bank's 13F filing for Q4 2021, filed 11 Feb 2022.